The Burden of Coronavirus Disease 2019 and Its Complications in Patients With Atopic Dermatitis—A Nested Case-Control Study
Authors:
- 15 June 2021
- journal article
- research article
- Published by SAGE Publications in Dermatitis®
- Vol. 32 (1S) , S45-S52
Abstract
Background The burden of coronavirus disease 2019 (COVID-19) among patients with atopic dermatitis (AD) is poorly understood. Objectives The aims of the study were to characterize a large cohort of COVID-19–positive adult patients with AD and to identify predictors of COVID-19–associated hospitalization and mortality. Methods A population-based nested case-control study was performed. Multivariable logistic regression was used to evaluate odds ratios and 95% confidence intervals of predictors for COVID-19–associated hospitalization and mortality. Results Of 78,073 adult patients with AD, 3618 (4.6%) tested positive for COVID-19. Subclinical COVID-19 infection occurred in 3368 (93.1%) of COVID-19–positive patients, whereas 123 (3.4%), 46 (1.3%), 55 (1.5%), and 26 (0.7%) patients developed a mild, moderate, severe, and critical disease, respectively. Altogether, 250 patients (6.0%) were hospitalized, and 40 patients (1.1%) died because of COVID-19 complications. Coronavirus disease 2019–associated hospitalization was independently associated with the intake of extended courses of systemic corticosteroids (adjusted odds ratio, 1.96; 95% confidence interval, 1.23–3.14; P = 0.005). None of AD-related variables independently predicted COVID-19–associated mortality. The presence of comorbid metabolic syndrome, chronic obstructive pulmonary disease, chronic renal failure, and depression projected both COVID-19–associated hospitalization and mortality. Conclusions Prolonged systemic corticosteroids during the pandemic are associated with increased odds of COVID-19–associated hospitalization and should be avoided in patients with AD.Keywords
This publication has 35 references indexed in Scilit:
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- The exposome in atopic dermatitisAllergy, 2019
- Increased Risk of Cutaneous and Systemic Infections in Atopic Dermatitis—A Cohort StudyJournal of Investigative Dermatology, 2017
- Association between atopic dermatitis and extracutaneous infections in US adultsBritish Journal of Dermatology, 2016
- Diagnosis of Atopic Dermatitis: Mimics, Overlaps, and ComplicationsJournal of Clinical Medicine, 2015
- Childhood atopic dermatitis and warts are associated with increased risk of infection: A US population-based studyJournal of Allergy and Clinical Immunology, 2014
- Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitisJournal of Allergy and Clinical Immunology, 2012
- Atopic Dermatitis: A Disease Caused by Innate Immune Defects?Journal of Investigative Dermatology, 2009
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO ConsultationDiabetic Medicine, 1998